BOSTON (AP) — BOSTON (AP) — Monte Rosa Therapeutics Inc. (GLUE) on Thursday reported a loss of $33.3 million in its fourth quarter.

The Boston-based company said it had a loss of 58 cents per share.

The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 57 cents per share.

For the year, the company reported a loss of $135.4 million, or $2.63 per share.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GLUE at https://www.zacks.com/ap/GLUE

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News